WAI CHUN BIOTEC(00660): Possible delay in publishing full-year performance.
Weijun Biotechnology (00660) issued an announcement that the company's Chief Financial Officer will be on leave from September 14, 2024 due to family reasons.
WAI CHUN BIOTEC (00660) announces that the company's Chief Financial Officer has resigned from September 14, 2024 due to personal reasons, causing hindrances in providing information and documents to the auditors. As a result, the company needs additional time to finalize the audited financial results for the year ending June 30, 2024, and it may be delayed beyond the original announcement date of September 30, 2024.
The company is working closely with the auditors to provide all required information and documents to expedite the auditing process. However, the expected announcement date for the annual results will need to be further determined with the auditors and will be announced separately.
Related Articles
HK Stock Market Move |
Huachuang Securities: Small and medium-sized brokerages still possess cyclical elasticity, and product capability determines development space.
HK Stock Market Move | Shenzhen Longsys Electronics (09976) rose over 7% in early trading, with a net profit exceeding 10 billion in the first half of the year. The company is a leading domestic memory module manufacturer.
HK Stock Market Move |
Huachuang Securities: Small and medium-sized brokerages still possess cyclical elasticity, and product capability determines development space.
HK Stock Market Move | Shenzhen Longsys Electronics (09976) rose over 7% in early trading, with a net profit exceeding 10 billion in the first half of the year. The company is a leading domestic memory module manufacturer.
RECOMMEND
